Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-30, Stock:JNJ, The news for the past five days is as follows:
2018-10-23: NEWS1: Edwards Lifesciences Earnings beat, Revenue misses In Q3.NEWS2: The fear gauge and strong earnings tell Jim Cramer this bottom in the stock market may be real.NEWS3: 3 Household Product Stocks to Keep Your Portfolio Clean and Safe Forever.NEWS4: 3 Household Product Stocks to Keep Your Portfolio Clean and Safe Forever.NEWS5: Why 3M Stock Should Be on Your “Wait and See” List Again.NEWS6: Why 3M Stock Should Be on Your “Wait and See” List Again.NEWS7: Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC.NEWS8: Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC.NEWS9: 3 Household Product Stocks to Keep Your Portfolio Clean and Safe Forever.NEWS10: Why 3M Stock Should Be on Your “Wait and See” List Again.NEWS11: Johnson & Johnson’s Interventional Solutions Business.NEWS12: How Is Novartis Valued?.NEWS13: Caterpillar Tanks, 3M Slumps Because Trade Woes Are Not Just for China Anymore.NEWS14: Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines.NEWS15: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS16: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS17: Biogen Inc Earnings, Revenue beat in Q3.NEWS18: Centene Earnings miss, Revenue beats In Q3.NEWS19: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS20: Health Care Sector Update for 10/23/2018: PTI, TTPH, BIIB, JNJ, PFE, ABT, MRK, AMGN.NEWS21: Health Care Sector Update for 10/23/2018: PTI, TTPH, BIIB, JNJ, PFE, ABT, MRK, AMGN.NEWS22: A Look into Johnson & Johnson’s Diabetes Care Business.NEWS23: ASML Slumps, J&J Slips as Worries Pound the Dow.NEWS24: J&J moves to buy Japanese cosmetic products company.NEWS25: J&J moves to buy Japanese cosmetic products company.NEWS26: Stocks making the biggest move premarket: UTX, HOG, VZ, MMM, CAT & more.NEWS27: J&J Makes Offer to Buy Japanese Cosmetics Firm Ci:z.NEWS28: How Johnson & Johnson’s Medical Device Business Stands Now.NEWS29: How Novartis’s Sandoz Performed in the Third Quarter.NEWS30: [$$] J&J to Buy Rest of Japanese Beauty Care Company.NEWS31: Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z.NEWS32: J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z.NEWS33: Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd..NEWS34: Johnson & Johnson To Buy Remaining Stake In Japan's Ci:z In Â¥230 Bln Deal.NEWS35: Johnson & Johnson To Buy Remaining Stake In Japan's Ci:z In Â¥230 Bln Deal.NEWS36: Johnson & Johnson (JNJ) Stock Moves -0.27%: What You Should Know.NEWS37: Johnson & Johnson (JNJ) Stock Moves -0.27%: What You Should Know.NEWS38: Why Aduro Biotech Crashed 29.5% Today.NEWS39: Why Aduro Biotech Crashed 29.5% Today.
2018-10-24: NEWS1: Vertex Earnings, Revenue miss in Q3.NEWS2: Recommendations for Allergan on October 24.NEWS3: Stelara and Simponi Drive Johnson & Johnson’s Immunology Business.NEWS4: How Analysts View Johnson & Johnson in October.NEWS5: Allergan’s Q3 2018 Earnings: Analysts’ Estimates.NEWS6: A Performance Overview of Johnson & Johnson.NEWS7: A Performance Overview of Johnson & Johnson’s Surgery Segment.NEWS8: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS9: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS10: Boston Scientific Earnings, Revenue miss in Q3.NEWS11: Drug Stocks&apos; Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS12: Health Care Sector Update for 10/24/2018: LH, ALXN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 10/24/2018: LH, ALXN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Thermo Fisher Scientific Earnings, Revenue Beats In Q3.NEWS15: JNJ’s Orthopedics Segment: Knees, Trauma, and Spine.NEWS16: An Overview of Johnson & Johnson’s Orthopedics Business.
2018-10-25: NEWS1: Stryker Earnings beat, Revenue misses In Q3.NEWS2: Gilead Earnings, Revenue beat in Q3.NEWS3: Noteworthy Thursday Option Activity: SHW, LPLA, JNJ.NEWS4: Noteworthy Thursday Option Activity: SHW, LPLA, JNJ.NEWS5: Merck & Co. Grows 5% in the Third Quarter.NEWS6: Notable ETF Inflow Detected - ACWI, MSFT, JNJ, XOM.NEWS7: Notable ETF Inflow Detected - ACWI, MSFT, JNJ, XOM.NEWS8: Celgene Earnings, Revenue beat in Q3.NEWS9: How JNJ’s Invega Sustenna and Risperdal Consta Performed.NEWS10: Merck&Co Earnings beat, Revenue misses In Q3.NEWS11: J&J Intends to Buy Residual Stake in Japanese Skincare Firm.NEWS12: Health Care Sector Update for 10/25/2018: ELGX, BMY, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 10/25/2018: ELGX, BMY, JNJ, PFE, ABT, MRK, AMGN.NEWS14: How Is Johnson & Johnson’s Neuroscience Business Positioned?.NEWS15: 3 Beaten-Down Biotech Stocks: Can They Bounce Back?.NEWS16: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS17: An Overview of Johnson & Johnson’s Infectious Diseases Business.NEWS18: How Is Johnson & Johnson’s Vision Care Business Positioned?.NEWS19: The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18).
2018-10-26: NEWS1: Court Issues Ruling in ZYTIGA® Patent Infringement Litigation.NEWS2: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS3: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS4: The health and wellness industry is making healthy profits.NEWS5: 'A New Way To Treat The Brain': Stanford University Scientists Launch Cannabis Pharma Company.NEWS6: Celgene’s Revlimid and Pomalyst Saw Solid Q3 Growth.NEWS7: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS8: How Is JNJ’s Cardiovascular & Metabolism Business Positioned?.NEWS9: Health Care Sector Update for 10/26/2018: SGYP, RARE, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Health Care Sector Update for 10/26/2018: SGYP, RARE, JNJ, PFE, ABT, MRK, AMGN.NEWS11: A Performance Overview of JNJ’s Imbruvica, Velcade, and Zytiga.NEWS12: Johnson & Johnson’s Oncology Business Saw Solid Growth in Q3.
2018-10-29: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Top Stock Picks for the Week of October 29th.NEWS3: Top Stock Picks for the Week of October 29th.NEWS4: Knock Offs Loom For J&J's Blockbuster — Why An Analyst Is Still Bullish.NEWS5: Biogen And Eisai May Be At Odds In Alzheimer's — So What Now?.NEWS6: Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel.NEWS7: Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel.NEWS8: Top Stock Picks for the Week of October 29th.NEWS9: Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel.NEWS10: GlaxoSmithKline’s Q3 2018 Revenue Expected to Grow.NEWS11: Stocks - RedHat Soars in Pre-market, IBM Falls, Tesla, Ford Jump.NEWS12: Health Care Digest: A small biotech goes head first, Gilead&apos;s lower tax rate and more.NEWS13: What&apos;s in the Cards for Geron (GERN) This Earnings Season?.NEWS14: A Performance Review of JNJ’s Pulmonary Hypertension Business.

Answer: Rise